OR7E157P

Across TCGA pan-cancer cohorts, OR7E157P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR7E157P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR7E157P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E157P expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

KIRP, MESO, and LUAD are the cancer types where OR7E157P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
MESO	DFS	Tertile	All	0.116	0.485	.004	27	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
THYM	OS	Quartile	All	0.496	0.934	.004	12	view →
ESCA	DFS	Tertile	All	0.383	0.530	.029	12	view →
KIRC	DFS	Tertile	All	0.454	0.665	.032	6	view →
OV	DFS	Tertile	IV	0.325	0.516	.035	6	view →
UCEC	OS	Tertile	II,III,IV	1.000	0.837	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR7E157P–KIRP (DFS)

Open the KIRP breakdown →